Table 3 CBCL profile of syndromes of studied group
Profile of syndromes | Children who had not COVID-19 (n=108) | Children who had COVID-19 (N=30) | Total participants (N=138) | Chi-square value | P-value | |
|---|---|---|---|---|---|---|
Withdrawn | Normal | 74 (68.5%) | 20 (66.7%) | 94 (68.1%) | 2.45 | 0.28 |
Borderline | 16 (14.8%) | 2 (6.7%) | 18 (13%) | |||
Clinical rating | 18 (16.7%) | 8 (26.7%) | 26 (18.8%) | |||
Somatic complaints | Normal | 100 (92.6%) | 18 (60%) | 118 (85.5%) | 24.82 | <0.000* |
Borderline | 6 (5.6%) | 4 (13.3%) | 10 (7.2%) | |||
Clinical rating | 2 (1.9%) | 8 (26.7%) | 10 (7.2%) | |||
Anxious/depressed | Normal | 80 (74.1%) | 18 (60%) | 98 (71%) | 2.25 | 0.33 |
Borderline | 14 (13%) | 6 (20%) | 20 (14.5%) | |||
Clinical rating | 14 (13%) | 6 (20%) | 20 (14.5%) | |||
Sleep problems | Normal | 102 (94.4%) | 24 (80%) | 126 (91.3%) | 6.17 | 0.04* |
Borderline | 2 (1.9%) | 2 (6.7%) | 4 (2.9%) | |||
Clinical rating | 4 (3.7%) | 4 (13.3%) | 8 (5.8%) | |||
Attention problems | Normal | 108 (100%) | 26 (86.7%) | 134 (97.1%) | 14.83 | 0.002* |
Borderline | 0 (0%) | 4 (13.3%) | 4 (2.9%) | |||
Clinical rating | 0 (0%) | 0 (0%) | 0 (0%) | |||
Emotionally reactive | Normal | 82 (75.9%) | 22 (73.3%) | 104 (75.4%) | 0.49 | 0.78 |
Borderline | 22 (20.4%) | 6 (20%) | 28 (20.3%) | |||
Clinical rating | 4 (3.7%) | 2 (6.7%) | 6 (4.3%) | |||
Aggressive behavior | Normal | 94 (87%) | 22 (73.3%) | 116 (84.1%) | 4.24 | 0.15 |
Borderline | 8 (7.4%) | 6 (20%) | 14 (10.1%) | |||
Clinical rating | 6 (5.6%) | 2 (6.7%) | 8 (5.8%) | |||
General profile of problems | ||||||
Internalizing problems | Normal | 74 (68.5%) | 18 (60%) | 92 (66.7%) | 2.64 | 0.26 |
Borderline | 10 (9.3%) | 6 (20%) | 16 (11.6%) | |||
Clinical rating | 24 (22.2%) | 6 (20%) | 30 (21.7%) | |||
Externalizing problems | Normal | 90 (83.3%) | 18 (60%) | 108 (78.3%) | 8.68 | 0.013* |
Borderline | 6 (5.6%) | 6 (20%) | 12 (8.7%) | |||
Clinical rating | 12 (11.1%) | 6 (20%) | 18 (13%) | |||
Total problems | Normal | 82 (75.9%) | 14 (46.7%) | 96 (69.6%) | 20.26 | <0.000* |
Borderline | 8 (7.4%) | 12 (40%) | 20 (14.5%) | |||
Clinical rating | 18 (16.7%) | 4 (13.3%) | 22 (15.9%) | |||